---
$id: https://graph.org.ai/products/commodity/51131622
$type: Product
source: UNSPSC
code: "51131622"
title: "Aprosulate"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Aprosulate

**UNSPSC Code**: 51131622
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent with the molecular formula C27H34N2O70S16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X94B38CQOM, chemically known as n,n-trimethylenebis(actobionamide) hexadecakis sulfate (ester) but generally known as aprosulate, which bears US NIH Compound Identifier 72125. European Medicines Agency schedules Aprosulate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05545MIG. The term APROSULATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). As of Q4 2014, APROSULATE remains the US FDA Preferred Term for this commodity. Aprosulate bears US NLM identifiers UMLS ID C0103894 and NCI Concept Code C87428. SMILES: C(CNC(=O)C(C(C(C(COS(=O)(=O)[O-])OS(=O)(=O)[O-])OC1C(C(C(C(O1)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])CNC(=O)C(C(C(C(COS(=O)(=O)[O-])OS(=O)(=O)[O-])OC2C(C(C(C(O2)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].

